Plain-English translation of NCT07091084 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a traditional herbal formula called Ma-Zi-Ren-Wan (MZRW) to see if it can help relieve constipation in cancer survivors. Researchers will compare this medication with a placebo (a pill that looks identical but contains no active ingredient) to understand whether the treatment truly works. The study will also examine how the medication affects your gut bacteria, which play an important role in digestion.
Many cancer survivors struggle with constipation after treatment, and safe, effective options are limited. This trial exists to find out whether this medication could offer a gentler, natural alternative for people dealing with this common and bothersome side effect.
You likely qualify if…
You likely don't qualify if…
You would be randomly assigned to receive either the herbal medication or a placebo for 2 weeks. Both look and are taken the same way. During the study, you'll track your bowel movements and symptoms, and researchers will likely collect information about your gut bacteria. The study is 'double-blinded,' meaning neither you nor the researchers will know which treatment you're receiving until the end — this helps ensure fair, unbiased results.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
United States